Advertisement

Topics

Latest "Brown Shoe Company" News Stories

16:05 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Brown Shoe Company" found in our extensive news archives from over 250 global news sources.

More Information about Brown Shoe Company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Brown Shoe Company for you to read. Along with our medical data and news we also list Brown Shoe Company Clinical Trials, which are updated daily. BioPortfolio also has a large database of Brown Shoe Company Companies for you to search.

Showing "Brown Shoe Company" News Articles 1–25 of 19,000+

Tuesday 18th December 2018

Eli Lilly and Company: Eli Lilly and Company Files an 8-K

Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company Files an 8-K 18-Dec-2018 / 20:46 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. ELI LILLY AND COMPANY FILES A FORM 8-K


Cyprotex Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCyprotex Ltd Cyprotex, a subsidiary of Evotec AG is a provider of ADMETox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company's core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including propriet...

Definiens AG Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryDefiniens AG Definiens, a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include consulting and planning services, image analysis solution services, integration and deployment services and...


Editas Medicine Inc EDIT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryEditas Medicine Inc Editas Medicine formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its inlicensed clustered regularly interspaced short palindromic repeats CRISPR technology. The company's preclinical pipeline spans investigational candidates fo...

Leadiant Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryLeadiant Biosciences Inc Leadiant Biosciences, formerly SigmaTau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matulane and revcovi, among others. It also offers services including patient support, discovery and develop...

EMA committee recommends approval of Bristol─Myers' Sprycel for paediatric patients with newly diagnosed PH+ ALL

Bristol─Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the expanded approval of Sprycel (dasatinib),

Recipharm AB RECI B Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecipharm AB Recipharm is a contract development and manufacturing organization CDMO that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semisolids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm's dev...

Memorial Sloan Kettering Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryMemorial Sloan Kettering Cancer Center MSKCC is a healthcare service provider that offers cancer treatment, cancer research and cancer education programs. The center conducts research in therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genet...

Onxeo Receives EPO Intent-to-Grant Notice for New Patent Protecting AsiDNA™ in Combination with Any PARP Inhibitor

Combination patent to be granted in Europe until 2036 Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology targeting tumor DNA Damage Response (DDR) to fight resistant cancers, today announced having been notified by the ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI

NEW YORK, Dec. 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Intra-Cellular Therapies, Inc. ("Intra-Cellular" or the "Company") (NASDAQ: ITCI) Investors ...

University of Washington Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryUniversity of Washington UoW is an educational institution that provides undergraduate, postgraduate and master's degrees. The university provides courses in the areas of accounting, aeronautics, applied mathematics, bioengineering, business, social sciences, science, law, medicine, and public affairs. It also offers services in nursing, health services, astronomy, computer science, molecul...

QRxPharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryQRxPharma Ltd QRxPharma develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR Q8003, an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV Q8012, an intravenous...

Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today announced the pricing of a “best efforts” public offering of  Company’s shares of common stock and warrants with expected total gross proceeds of up to $2.5 million. &#...

Maxar's SSL Awarded Contract to Provide GEO SmallSat for Mobile Broadband Company

SSL expands offerings with innovative geostationary satellite for Ovzon's high performance network PALO ALTO, CA, Dec. 18, 2018 /PRNewswire/ - SSL, a Maxar Technologies company Read more...

Invesco Income Growth Trust Plc - Director Declaration

Invesco Income Growth Trust plc (‘the Company’) Director’s Other Directorship This announcement is to record, as required by Listing Rule 9.6.14, that Jonathan Silver, a Read more...

Worldwide Healthcare Trust Plc - Issue of Equity

WORLDWIDE HEALTHCARE TRUST PLC 18 December 2018 Allotment of Ordinary Shares WORLDWIDE HEALTHCARE TRUST PLC (the “Company”) announces the allotment of 10,000 Ordinary shares of Read more...

Herbalife Nutrition and LA Galaxy Join Forces to Inspire Positive Nutrition and Fitness Habits in Indonesia and Japan

TOKYO, Dec. 18, 2018 /PRNewswire/ -- Herbalife Nutrition (NYSE: HLF), a premier global nutrition company whose purpose is to make the world healthier and happier, has joined forces with America's Major League Soccer (MLS) team, LA Galaxy, to inspire positive nutrition and fitness habits in Asia. Herbalife Nutrition has been the official nutrition and jersey partner for LA Galaxy since 2007.

Lilly Announces Publication of Analyses Showing Benefit of Addition of Verzenio in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having More Concerning Prognosis

INDIANAPOLIS, Dec. 18, 2018 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced npj Breast Cancer published results from exploratory subgroup analyses of the MONARCH 2 and MONARCH 3 trials reinforcing the clinical benefit of Verzenio® (abemaciclib) plus endocrine therapy in the treatment of women with hormone receptor-positive (HR+), human epi...

Bristol-Myers Squibb and Boston Medical Center Collaborate to Investigate Markers of Immuno-Oncology Response and Resistance

NEW YORK & BOSTON–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY), and Boston Medical Center, a private, not-for-profit, academic medical center, today announced a multi-year joint research study to identify and analyze potential sensitivity and resistance markers in patients treated with standard-of-care checkpoint inhibitors. The comprehensive, multi-dimensional study w...

Puma Announces Top Line Results of the Phase 3 Trial of Neratinib in Patients with HER2-Positive Metastatic Breast Cancer

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced top line results from the Phase III NALA trial of the Company’s lead drug candidate PB272 (neratinib) in patients with HER2-positive metastatic breast cancer who have failed two or more prior lines of HER2-directed treatments (third-line disease) in the setting of metastati...

Cesca Therapeutics Inc KOOL Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCesca Therapeutics Inc Cesca researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cellbased therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The compan...

Therma Bright Inc. Issues Update on Pain Relief Device and TherOZap(TM) Technology

Therma Bright Inc. (TSXV:THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, today announces that it has received the prototype of its pain relief device and provides an update on its TherOZap™ technology. The post Therma Bright Inc. Issues Update on Pain Relief Device and TherOZap(TM) Technology appeared first on Investing News Network.

Toleranzia AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryToleranzia AB Toleranzia is a drug developer that utilizes immune system's intrinsic power to treat autoimmune diseases. The company offers products and technologies including ReTolerogen for the treatment of autoimmune diseases. Its ReTolerogen platform technology is a fusion protein for the treatment of malfunctioning immune system. Toleranzia develops a treatment specifically for myasthe...

KCI Announces First-of-its-Kind Negative Pressure Wound Therapy Agreement with Highmark to Improve Patient Engagement, Raise Adherence and Lower Costs

KCI, an Acelity Company, a global leader in advanced wound management, and Highmark Inc., a national diversified health care insurance provider, today announced they have entered into a performance-based agreement for the KCI iOn PROGRESS™ Remote Therapy Monitoring Program which aims to improve overall patient experience, while lowering costs through inc...

Rapid Micro Biosystems Inc Medical Equipment Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryRapid Micro Biosystems Inc Rapid Micro Biosystems, formerly Genomic Profiling Systems is a laboratory equipment supplier that offers faster detection of personal care products. The company provides products for the detection of microbial contamination in the manufacture of biotechnology, pharmaceutical and personal care products. It offers products such as growth direct system, growth casse...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks